Inside Innovation

Century Therapeutics and Bristol Myers Squibb (BMS) are collaborating on four programs for hematologic malignancies and tumors. BMS, which has a presence in Seattle, will

Absci, a Washington-based life science company has announced a collaboration with Merck worth up to $610 million in milestone payments and upfront fees. Under the

The University of Washington has officially opened the Center for Medication Development for Substance Use Disorders after raising more than $2 million in funding. Researchers

Good Therapeutics, a Seattle startup, has raised $8 million toward advancing therapeutic proteins aimed at helping cancer patients. With 22 employees total, the company is

After announcing it was raising a $6 million Series A last March, Curi Bio Inc., a Seattle life science startup has closed a $10 million

Since acquiring Celgene and its Seattle operations a couple years ago, Bristol Meyers Squibb (BMS) has been growing its presence in the Seattle area. Now,

Bristol Myers Squibb (BMS), which has several facilities in Washington state, is making significant advancements with Breyanzi, a CD19-directed CAR-T cell therapy as a second

A consortium to begin the development of the next COVID-19 vaccine is underway at The Infections Disease Research Institute (IDRI). The Washington-based non-profit is working

A new CBRE report reveals that as the life science industry continues to boom in the Seattle area, companies are buying out lab space and

Omeros, a Seattle-based biotech company, has announced it is selling its Omidria franchise to Rayner Surgical Group. Omidria helps to prevent excessive pupil constriction in

The Association of Washington Business has named David Hojah, Entrepreneur of the Year. Hojah is the CEO and Founder of Parrots Inc., a Spokane-based medical

Tune Therapeutics, a new biotech company with roots in Seattle, has developed TEMPO, a epigenomic therapy platform. TEMPO can find epigenomic elements contributing to genetic